LifeStance Health Group, Inc.LFSTNASDAQ
Loading
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +15.99% | +10.83% | +10.56% | +16.34% | +17.43% |
| Gross Profit Growth | +31.35% | +15.90% | -3.46% | +16.08% | +3.13% |
| EBITDA Growth | +0.00% | +98.62% | +508.44% | +38.27% | +107.44% |
| Operating Income Growth | +0.00% | +0.00% | +0.00% | +15665.96% | +1642.12% |
| Net Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Diluted Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Weighted Average Shares Growth | +1.06% | +1.84% | +1.47% | +2.18% | +0.86% |
| Weighted Average Shares Diluted Growth | +1.06% | +3.81% | +1.47% | +2.69% | +2.19% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +271.04% | +0.00% | +46.16% | +20.09% | -7.63% |
| Free Cash Flow Growth | +940.98% | +0.00% | +45.42% | -3.82% | +47.77% |
| Receivables Growth | +5.08% | -20.22% | -22.57% | -23.45% | -27.51% |
| Inventory Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Asset Growth | +0.39% | -0.08% | +1.30% | +1.95% | +4.04% |
| Book Value per Share Growth | +0.15% | +0.12% | +1.57% | +1.66% | +4.27% |
| Debt Growth | -5.06% | -6.48% | -4.64% | -2.68% | -60.00% |
| R&D Expense Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| SG&A Expenses Growth | +0.36% | +6.18% | +2.34% | +12.22% | +1.06% |